Who owns NewAmsterdam Pharma Co N.V. (NAMS)? Elite investor 13F holders
4 tracked elite investors reported holding NewAmsterdam Pharma Co N.V as of 2026-06-30, including Viking Global Investors, Maverick Capital, D.E. Shaw, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Viking Global Investors | Newamsterdam Pharma Company | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 142458886.00 USD | 4203567.000000 | Shares | hold | Original filing |
| Maverick Capital | Newamsterdam Pharma Company | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 110745810.00 USD | 3267802.000000 | Shares | add | Original filing |
| Duquesne Family Office | Newamsterdam Pharma Company | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| D.E. Shaw | Newamsterdam Pharma Company | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4085812.00 USD | 120561.000000 | Shares | buy | Original filing |
| Tudor Investment | Newamsterdam Pharma Company | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2692899.00 USD | 79460.000000 | Shares | buy | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.